Table 1.
Clinical Details of Amblyopic Subjects
| Subject's Initials | Task | Age | M/F | Amb Eye | Refractive Error | VA | Strab | Amblyopia Type | Treatment History |
|---|---|---|---|---|---|---|---|---|---|
| DC | GA/LC | 42 | F | L | R pl/−0.75 × 85 | 0.00 | LSOT | Strab and aniso | Specs and occlusion |
| L +3.00 DS | 0.94 | ||||||||
| NGM | GA | 29 | M | R | R +3.00/−1.00 × 60 | 0.32 | NMD | Aniso | Specs and occlusion |
| L +0.50 DS | −0.02 | ||||||||
| PCP | GA | 40 | M | R | R +3.75/−0.75 × 55 | 0.24 | RSOT | Strab and aniso | Specs and occlusion |
| L +1.00/−0.50 × 175 | −0.22 | ||||||||
| RLC | GA | 29 | M | L | R +0.25 DS | 0.00 | NMD | Aniso | Specs and occlusion |
| L +2.50/−1.00 × 60 | 0.24 | ||||||||
| MP | GA/LC | 52 | M | R | R +4.50/−1.00 × 80 | 0.70 | NMD | Aniso | Specs |
| L +1.50/−0.25 × 30 | −0.30 | ||||||||
| LE | GA/LC | 54 | M | L | R −5.25/−0.50 × 85 | 0.00 | NMD | Aniso | Specs and occlusion |
| L −0.50/−2.00 × 170 | 0.50 | ||||||||
| TS | GA | 45 | F | L | R pl | 0.04 | NMD | Aniso | Specs and occlusion |
| L +4.75/−0.50 × 180 | 0.80 | ||||||||
| JW | GA | 55 | F | L | R +0.75/−0.25 × 75 | 0.00 | NMD | Aniso | Specs |
| L +4.50/−1.00 × 30 | 0.28 | ||||||||
| CM | LA | 24 | F | L | R +0.25 DS | −0.08 | NMD | Aniso | Specs and occlusion |
| L +0.25/−2.50 × 55 | 0.28 | ||||||||
| WT | LA | 44 | F | L | R +0.25 DS | 0.00 | LSOT | Strab and aniso | Strab op, specs and occlusion |
| L +3.00/−2.00 × 10 | 1.30 | ||||||||
| CH | LA | 50 | M | L | R +2.75/−1.75 × 65 | 0.02 | L microt | Strab | None |
| L −3.75/−0.50 × 85 | 0.32 | ||||||||
| AG | LA | 42 | M | R | R −4.00/−1.00 × 165 | 0.50 | RXOT +L/R tropia | Strab | None |
| L −4.75/−0.50 × 25 | 0.02 | ||||||||
| ACT | LA | 31 | F | L | R +3.00/−1.50 × 45 | −0.06 | LSOT | Strab and aniso | Specs and occlusion |
| L +4.25/−3.00 × 157 | 0.16 | ||||||||
| AS | GC | 47 | M | L | R −1.75/−1.00 × 30 | −0.10 | LSOT | Strab and aniso | Specs and occlusion |
| L +3.50/−0.25 × 10 | 0.80 | ||||||||
| KAN | GC | 63 | F | L | R +1.50/−0.25 × 130 | −0.20 | LSOT | Strab | None |
| L +1.50/−1.00 × 105 | 0.80 | ||||||||
| SB | GC | 37 | F | L | R −1.00 DS | 0.00 | NMD | Aniso | Specs and occlusion |
| L +4.00 DS | 0.90 | ||||||||
| EF | GC | 45 | M | R | R +5.50/−2.00 × 130 | 0.60 | NMD | Aniso | Specs and occlusion |
| L −0.25/−0.75 × 45 | −0.22 | ||||||||
| CMW | GC | 22 | M | R | R +4.75 DS | 0.60 | NMD | Aniso | Specs and occlusion |
| L pl | −0.10 | ||||||||
| FH | GC | 33 | F | R | R +3.00/−2.00 × 135 | 0.32 | NMD | Aniso | Specs |
| L pl | 0.00 | ||||||||
| BM | LC | 27 | F | L | R +3.75/−0.50 × 140 | 0.24 | LSOT | Strab and aniso | Specs and occlusion |
| L +5.50/2.00 × 55 | 0.84 | ||||||||
| CB | LC | 21 | F | R | R +4.00/−0.25 × 110 | 0.14 | NMD | Aniso | Specs and occlusion |
| L +0.75/−0.25 × 180 | −0.16 | ||||||||
| JN | LC | 17 | F | R | R +3.00/−1.00 × 10 | 0.20 | NMD | Aniso | Specs and occlusion |
| L pl | −0.06 | ||||||||
| KR | LC | 56 | M | L | R +2.00/−0.50 × 10 | −0.24 | LXOT +R/L tropia | Strab and aniso | Strab op, specs and occlusion |
| L +3.50 DS | 0.82 | ||||||||
| KT | LC | 26 | F | R | R −4.00/−2.00 × 10 | 1.35 | R Microt | Strab and aniso | Specs and occlusion |
| L −1.75/−0.50 | 0.02 | ||||||||
| RL | LC | 47 | M | R +L | R +8.00/−2.50 × 18 | 0.26 | NMD | Bilateral hypermetropic | Specs |
| L +7.75/−1.50 × 12 | 0.18 | ||||||||
| IMB | LC | 41 | M | L | R +0.50DS | −0.10 | NMD | Aniso | Specs and occlusion |
| L +5.50/−0.25 × 180 | 0.62 |
M, male; F, female; Amb, amblyopia; Strab, strabismus; GA, grating acuity; LA, letter acuity; GC, grating contrast; LC, letter contrast; R, right; L, left; pl, plano; VA, initial visual acuity (logMAR with Bailey-Lovie); NMD, no movement detected; RSOT/LSOT, right/left esotropia; RXOT/LXOT, right/left exotropia; Aniso, anisometropia; Specs, spectacles; R/L tropia, right hypertropia; L/R, left hypertropia; microt, microtropia. Subjects DC; MP and LE were trained on GA then LC.
Subject RL: (bilateral amblyopia) RE was trained.